Guangdong Tai'an Tang Pharmaceutical Co., Ltd. has received a prior notice from the Shenzhen Stock Exchange regarding the potential delisting of its shares due to an audit report for the 2022 fiscal year that could not express an opinion. The company’s stock has been under delisting risk warning since May 5, 2023. The company must respond by May 10, 2024, and has the right to request a hearing.
Summary generated by AI · Always verify with source document
Stock Code: 002433
Stock Abbreviation: *ST Tai'an
Announcement Number: 2024-041
Guangdong Tai'an Tang Pharmaceutical Co., Ltd. and all members of the board of directors guarantee that the content of the information disclosure is true, accurate, and complete, without false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.